Penn Medicine Provider
Gastroenterology
Bryson Katona, MD, PhD
5.0
(266)
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Perelman
Make an appointmentCall 215-349-8222

About me

  • Director, Gastrointestinal Cancer Genetics Program
  • Director, Lynch Syndrome Program
  • Director, Gastrointestinal Cancer Risk Evaluation Program
  • Member, Abramson Cancer Center
  • Jeffery and Cynthia King Associate Professor of Lynch Syndrome Research
  • Associate Professor of Genetics

Dr. Katona is a physician-scientist specializing in risk assessment and management of hereditary Gastrointestinal Cancer predisposition syndromes. At Penn Medicine’s Abramson Cancer Center, he serves as the Director of the Gastrointestinal Cancer Genetics Program and as the Director of the Lynch Syndrome Program.

Education and training

  • Medical School: Washington University in St. Louis
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

266 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

August 2025
5.0
5.0
overall, very professional and informative
August 2025
5.0
5.0
very professional and knowledgeable
July 2025
5.0
5.0
dr. katona is a phenomenal physician.
July 2025
5.0
5.0
i was extremely impressed by the diligence and experience.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Katona is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Fernandes CJ, Du YK, Naumer A, Kagami LA, Le A, Good M, Duvall M, Powers J, Zelley K, Maese LD, MacFarland S, Kohlmann W, Maxwell KN, Katona BW. Pancreatic Cancer Risk and Screening Outcomes in Li-Fraumeni Syndrome , Pancreas, 54: 2025,e618-e623

Bracht SA, Rong J, Gier RA, DeMarshall M, Golden H, Dhakal D, McDevitt JC, Mo F, Furth EE, Starling AS, Muir AB, Falk GW, Katona BW, Stanger BZ, Zhang NR, Shaffer SM. Mitochondrial clone tracing within spatially intact human tissues , bioRxiv: 2025

Shaukat A, Burke CA, Chan AT, Grady WM, Gupta S, Katona BW, Ladabaum U, Liang PS, Liu JJ, Putcha G, Robertson DJ, Schoen RE, Meng Z, Piscitello A, Sun CK, Xu C, Lin CJ, Lee LC, Baldo L, Levin TR; PREEMPT CRC Investigators. Clinical Validation of a Circulating Tumor DNA-Based Blood Test to Screen for Colorectal Cancer , JAMA, 334: 2025,56-63

Dudley B, Katona BW. Improving uptake of germline genetic testing amongst individuals at high-risk of pancreatic ductal adenocarcinoma , Transl Gastroenterol Hepatol, 10: 2025,41

Palma NA, Lucas AL, Katona BW, Athanasiou A, Kureshi NM, Ford L, Keller T, Weber S, Schiess R, King T, Simeone DM, Brand R. A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals , Cancers (Basel), 17: 2025,1866

Katona BW, Stanich PP, Chittenden A, Hall MJ, Idos GE, Koptiuch C, Latham A, Pearlman R, Singh A, Levinson E, Dudley B. Strategic Plan of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC): A practical roadmap to move the hereditary gastrointestinal cancer field forward , Fam Cancer, 24: 2025,51

Haider M, Masood M, Katona BW, Burke CA, Mankaney GN. Worldwide Impact of Upper Gastrointestinal Disease in Familial Adenomatous Polyposis , Diagnostics (Basel), 15: 2025,1218

Latham A, Liu YL, Constantino G, Borio M, McCoy S, Dudzik C, Heiman J, Kemel Y, Ukaegbu C, Carlo MI, Ranganathan M, Kane S, Long JM, Syngal S, Markowitz AJ, Stadler ZK, Yurgelun MB, Katona BW. Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6 / PMS2 -Associated Lynch Syndrome , Am J Gastroenterol: 2025

Heller M, Mann DA, Katona BW. Current Approaches of Pancreatic Cancer Surveillance in High-Risk Individuals , J Gastrointest Cancer, 56: 2025,61

Katona BW, Lubinski J, Pal T, Huzarski T, Foulkes WD, Moller P, Eisen A, Randall Armel S, Neuhausen SL, Raj R, Aeilts A, Singer CF, Bordeleau L, Karlan B, Olopade O, Tung N, Zakalik D, Kotsopoulos J, Fruscio R, Eng C, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation , Cancer, 131: 2025,e35666

View all publications